COVID-19 vaccination in patients with rheumatic diseases — status February 2022
Rheumatology Forum · 2022
DOI: 10.5603/fr.2021.0020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology Forum, 2022. Verfasst von Violetta Opoka-Winiarska und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Vaccination is the most effective strategy to prevent and reduce the effects of the COVID-19 pandemic. The purpose of this article is to summarize the current data and recommendations regarding vaccination against COVID-19 in children and adults with rheumatic diseases in Poland and worldwide. This paper also shows reports on vaccination in adults and children with rheumatic diseases, including efficacy, safety and adverse effects. Furthermore, ACR and PRES recommendations for COVID 19 vaccination in adults and children with rheumatic diseases were presented, including special situations that cause difficulties in daily clinical practice.
Zitieren
APA
Opoka-Winiarska, V., & Smolewska, E. (2022). COVID-19 vaccination in patients with rheumatic diseases — status February 2022. Rheumatology Forum. https://doi.org/10.5603/fr.2021.0020
Vancouver
Opoka-Winiarska V, Smolewska E. COVID-19 vaccination in patients with rheumatic diseases — status February 2022. Rheumatology Forum. 2022. doi:10.5603/fr.2021.0020
BibTeX
@article{OpokaWiniarska2022,
author = {Opoka-Winiarska, Violetta and Smolewska, Elżbieta},
title = {COVID-19 vaccination in patients with rheumatic diseases — status February 2022},
journal = {Rheumatology Forum},
year = {2022},
doi = {10.5603/fr.2021.0020}
}
EUVIMED